Biocon refuted media reports that said the company is evaluating a plan to sell its generic active pharmaceutical ingredient (API) business. (Image Credits: Pixabay) Biocon on Friday refuted media ...
“When I worked at Cambrex, I learned that generics are kind of boring,” says Kenneth Drew, senior director of North American sales and business development at Flamma, an Italian manufacturer of active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback